ArticleFrontiers in oncology2021

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer.

Soong June Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.